Body dysmorphic disorder

Seminars in Cutaneous Medicine and Surgery

Volumn 32, Issue 2, 2013, Pages 78-82

  Gupta, Rishu ^a   Huynh, Monica ^b   Ginsburg, Iona H ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Body dysmorphic disorder; Cognitive behavioral therapy; Psychocutaneous disease; Psychodermatology; Quality of life; Serotonin reuptake inhibitors

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; LITHIUM; PIMOZIDE; PLACEBO; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ARTICLE; BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; DELUSION; DISEASE CLASSIFICATION; DSM-IV; HUMAN; METACOGNITION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SUICIDE; CLASSIFICATION; DERMATOLOGY; HEALTH; METHODOLOGY; MORBIDITY; PSYCHIATRY; REVIEW; SKIN DISEASE;

BODY DYSMORPHIC DISORDERS; DERMATOLOGY; HUMANS; MORBIDITY; PSYCHIATRY; SKIN DISEASES; WORLD HEALTH;

EID: 84886939092     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.12788/j.sder.0005     Document Type: Article

References (79)

1. Phillips KA, Grant J, Siniscalchi J, Abertini RS. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics. 2001;42(6):504-510
2. Crerand CE, Phillips KA, Menard W, Fay C. Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics. 2005;46(6): 549-555
3. Tignol J, Biraben-Gotzamanis L, Martin-Guehl C, Grabot D, Aouizerate B. Body dysmorphic disorder and cosmetic surgery: evolution of 24 subjects with a minimal defect in appearance 5 years after their request for cosmetic surgery. Eur Psychiatry. 2007;22(8):520-524
4. Vargel S, Uluşahin A. Psychopathology and body image in cosmetic surgery patients. Aesthetic Plast Surg. 2001;25(6):474-478
5. Morselli E. Sulla dismorfofobia e sulla tafefobia. Bolletinno della R Accademia di Genova. 1891;6:110-119
6. Cotterill JA. Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol. 1981;104(6): 611-619
7. Hay GG. Dysmorphophobia. Br J Psychiatry. 1970;116(533):399-406
8. Ladee GA. Hypochondriacal Syndromes. Amsterdam: Elsevier; 1966
9. Munro A. Monosymptomatic hypochondriacal psychosis. Br J Hosp Med. 1980;24(1):34, 36-38
10. Zaidens SH. Dermatologic hypochondriasis; a form of schizophrenia. Psychosom Med. 1950;12(4):250-253
11. American Psychiatric Association. Task Force on Nomenclature and Statistics., American Psychiatric Association. Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 3d ed. Washington, D.C.: American Psychiatric Association; 1980
12. American Psychiatric Association. Work Group to Revise DSM-III. Diagnostic and statistical manual of mental disorders: DSM-III-R. 3rd ed. Washington, DC: American Psychiatric Association; 1987
13. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000
14. Phillips KA. Understanding Body Dysmorphic Disorder: an Essential Guide. New York: Oxford University Press; 2009
15. Buhlmann U, Glaesmer H, Mewes R, et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res. 2010;178(1):171-175
16. Faravelli C, Salvatori S, Galassi F, Aiazzi L, Drei C, Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. 1997;32(1):24-29
17. Koran LM, Abujaoude E, Large MD, Serpe RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008;13(4):316-322
18. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. 2001;158(12):2061-2063
19. Aouizerate B, Pujol H, Grabot D, et al. Body dysmorphic disorder in a sample of cosmetic surgery applicants. Eur Psychiatry. 2003;18(7):365-368
20. Castle DJ, Molton M, Hoffman K, Preston NJ, Phillips KA. Correlates of dysmorphic concern in people seeking cosmetic enhancement. Aust N Z J Psychiatry. 2004;38(6):439-444
21. Ishigooka J, Iwao M, Suzuki M, Fukuyama Y, Murasaki M, Miura S. Demographic features of patients seeking cosmetic surgery. Psychiatry Clin Neurosci. 1998;52(3):283-287
22. Nierenberg AA, Phillips KA, Petersen TJ, et al. Body dysmorphic disorder in outpatients with major depression. J Affect Disord. 2002;69(1-3):141-148
23. Phillips KA, Dufresne RG, Jr., Wilkel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol. 2000;42(3):436-441
24. Sarwer DB, Wadden TA, Pertschuk MJ, Whitaker LA. Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plast Reconstr Surg. 1998;101(6):1644-1649
25. Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997;11(5):499-502
26. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46(4):317-325
27. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44(4):270-276
28. Grant JE, Menard W, Pagano ME, Fay C, Phillips KA. Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry. 2005;66(3):309-316; quiz 404-405
29. Andreasen NC, Bardach J. Dysmorphophobia: symptom or disease? Am J Psychiatry. 1977;134(6):673-676
30. Phillips KA, Didie ER, Menard W, Pagano ME, Fay C, Weisberg RB. Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res. 2006;141(3):305-314
31. Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2005;2(4):395-400
32. Didie ER, Menard W, Stern AP, Phillips KA. Occupational functioning and impairment in adults with body dysmorphic disorder. Compr Psychiatry. 2008;49(6):561-569
33. Ishak WW, Bolton MA, Bensoussan JC, et al. Quality of life in body dysmorphic disorder. CNS Spectr. 2012;17(4):167-175
34. Veale D, Riley S. Mirror, mirror on the wall, who is the ugliest of them all? The psychopathology of mirror gazing in body dysmorphic disorder. Behav Res Ther. 2001;39(12):1381-1393
35. Grant JE, Odlaug BL. Update on pathological skin picking. Curr Psychiatry Rep. 2009;11(4):283-288
36. Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis. 2000;188(3):170-175
37. Kelly MM, Walters C, Phillips KA. Social anxiety and its relationship to functional impairment in body dysmorphic disorder. Behav Ther. 2010; 41(2):143-153
38. Fang A, Hofmann SG. Relationship between social anxiety disorder and body dysmorphic disorder. Clin Psychol Rev. 2010;30(8):1040-1048
39. Pinto A, Phillips KA. Social anxiety in body dysmorphic disorder. Body Image. 2005;2(4):401-405
40. Veale D. Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image. 2004;1(1):113-125
41. Didie ER, Loerke EH, Howes SE, Phillips KA. Severity of interpersonal problems in individuals with body dysmorphic disorder. J Pers Disord. 2012;26(3):345-356
42. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry. 2001;62(7):517-522
43. Conrado LA, Hounie AG, Diniz JB, et al. Body dysmorphic disorder among dermatologic patients: Prevalence and clinical features. J Am Acad Dermatol. 2010;63(2):235-243
44. Mancuso SG, Knoesen NP, Castle DJ. Delusional versus nondelusional body dysmorphic disorder. Compr Psychiatry. 2010;51(2):177-182
45. Phillips KA, Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. 2008;5(1):13-27
46. Phillips KA, McElroy SL, Keck PE, Jr., Hudson JI, Pope HG Jr. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30(2):179-186
47. Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res. 2008; 42(9):701-707
48. Lucchelli JP, Bondolfi G, Bertschy G. Body dysmorphic disorder, psychosis and insight: a report of four cases. Psychopathology. 2006;39(3): 130-135
49. Phillips KA. Psychosis in body dysmorphic disorder. J Psychiatr Res. 2004;38(1):63-72
50. Phillips KA, Wilhelm S, Koran LM, et al. Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety. 2010;27(6):573-591
51. Phillips KA. Suicidality in Body Dysmorphic Disorder. Prim psychiatry. 2007;14(12):58-66
52. Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005;66(6):717-725
53. Veale D, Boocock A, Gournay K, et al. Body dysmorphic disorder. A survey of fifty cases. Br J Psychiatry. 1996;169(2):196-201
54. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry. 2006;163(7):1280-1282
55. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205-228
56. Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics. 2004;45(5): 438-444
57. National Institute for Health and Clinical Excellence: Guidance. Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder. Leicester (UK): British Psychological Society; 2006
58. Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev. 2009;(1): CD005332
59. Perugi G, Giannotti D, Di Vaio S, Frare F, Saettoni M, Cassano GB. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol. 1996;11(4):247-254
60. Hollander E, Cohen L, Simeon D, Rosen J, DeCaria C, Stein DJ. Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol. 1994;14(1):75-77
61. Hollander E, Allen A, Kwon J, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56(11):1033-1039
62. Phillips KA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006;21(3):177-179
63. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59(4):165-171
64. Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64(6):715-720
65. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59(4):381-388
66. Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry. 1989;146(6):768-770
67. Phillips KA. An open study of buspirone augmentation of serotoninreuptake inhibitors in body dysmorphic disorder. Psychopharmacol Bull. 1996;32(1):175-180
68. Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chartreview study. J Clin Psychiatry. 2001;62(9):721-727
69. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993;150(2):302-308
70. Goulia P, Mantas C, Bassukas ID, Hyphantis T. Treatment with risperidone and venlafaxine of a patient with double-coded diagnosis of body dysmorphic disorder and delusional disorder somatic type. Hippokratia. 2011;15(3):286-287
71. Cotterill JA. Body dysmorphic disorder. Dermatol Clin. 1996;14(3): 457-463
72. Grant JE. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001;62(4):297-298
73. Nakaaki S, Murata Y, Furukawa TA. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry Clin Neurosci. 2008;62(3):370
74. Marks I, Mishan J. Dysmorphophobic avoidance with disturbed bodily perception. A pilot study of exposure therapy. Br J Psychiatry. 1988; 152:674-678
75. Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr. 2012;7(6):464-471
76. Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther. 1999;37:71(1)75
77. Neziroglu F, McKay D, Todaro J, Yaryura-Tobias J. Effect of cognitive behavior therapy on persons with body dysmorphic disorder and comorbid axis II diagnoses. Behav Ther. 1996;27(1):67-77
78. Rosen JC, Reiter J, Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263-269
79. Rabiei M, Mulkens S, Kalantari M, et al. Metacognitive therapy for body dysmorphic disorder patients in Iran: acceptability and proof of concept. J Behav Ther Exp Psychiatry. 2012;43:724-729